National Quality Measures Clearinghouse | Measures by Topic: Lung Neoplasms

National Quality Measures Clearinghouse | Measures by Topic: Lung Neoplasms

November 4, 2013

Measures by Topic

Disease/Condition > Diseases (1460) > Neoplasms (181) > Neoplasms by Site (118) > Thoracic Neoplasms (7) > Respiratory Tract Neoplasms (7) >

Lung Neoplasms (5)

Narrow:

Bronchial Neoplasms (1)

Bronchial Neoplasms (1)

'' (Clear)

and '' (Clear)

Search Within Search within:   Go

Sort results by:  Relevance (what's this?)    Publication date

Filter results by: All Years 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1997 1990

1-5 of 5
1.   Oncology: percentage of patients, regardless of age, with a diagnosis of pancreatic or lung cancer who receive 3D conformal radiation therapy with documentation in medical record that radiation dose limits to normal tissues were established prior to the initiation of a course of 3D conformal radiation for a minimum of two tissues. 2010 Sep. NQMC:003767 American Society for Therapeutic Radiology and Oncology - Medical Specialty Society; American Society of Clinical Oncology - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
2.   Cancer - dyspnea: percentage of inpatients with primary lung cancer or advanced cancer with dyspnea on admission who were offered symptomatic management or treatment directed at an underlying cause within 24 hours. 2010 Apr. NQMC:006149 RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s) Compare Selected
3.   Cancer - dyspnea: percentage of outpatients with primary lung cancer or advanced cancer who reported new or worsening dyspnea who were offered symptomatic management or treatment directed at an underlying cause within one month. 2010 Apr. NQMC:006148 RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s) Compare Selected
4.   Cancer - dyspnea: percentage of patients in the hospital treated for dyspnea who had an assessment within 24 hours that the treatment was effective in relieving dyspnea or that a change in treatment for dyspnea was made. 2010 Apr. NQMC:006150 RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s) Compare Selected
5.   Cancer - dyspnea: percentage of patients who reported new or worsening dyspnea for whom there was documentation of cause or of investigation of at least one of the following: hypoxia, anemia, bronchospasm or chronic obstructive pulmonary disease, pleural effusion, tumor obstruction of bronchi or the trachea, pneumonia, or pulmonary embolism. 2010 Apr. NQMC:006147 RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s)